Page 23 - 80_02

Carlos
Alonso,
Manuel
Soto

70
Soto,
M.;
Requena,
J.
M.;
Quijada,
L.;
Guzman,
F.;
Patarroyo,
M.
E.;
Alonso,
C.
Identification

of
the
Leishmania
infantum
P0
ribosomal
protein
epitope
in
canine
visceral
leishmaniasis.

Immunology
Letters
48,
23-­-28(1995).

71
Soto,
M.;
Requena,
J.
M.;
Quijada,
L.;
Alonso,
C.
Specific
serodiagnosis
of
human

leishmaniasis
with
recombinant
Leishmania
P2
acidic
ribosomal
proteins.
Clinical
and

Diagnostic
Laboratory
Immunology
3,
387-­-391
(1996).

72
Elkon,
K.;
Skelly,
S.;
Parnassa,
A.;
Moller,
W.;
Danho,
W.;
Weissbach,
H.;
Brot,
N.

Identification
and
chemical
synthesis
of
a
ribosomal
protein
antigenic
determinant
in

systemic
lupus
erythematosus.
Proccedings
of
the
National
Academy
Sciences
U.S.A
83,

7419-­-7423
(1986).

73
Iborra,
S.;
Soto,
M.;
Carrion,
J.;
Nieto,
A.;
Fernandez,
E.;
Alonso,
C.;
Requena,
J.
M.
The

Leishmania
infantum
acidic
ribosomal
protein
P0
administered
as
a
DNA
vaccine
confers

protective
immunity
to
Leishmania
major
infection
in
BALB/c
mice.
Infection
and

Immunity.
71,
6562-­-6572
(2003).

74
Iborra,
S.;
Carrion,
J.;
Anderson,
C.;
Alonso,
C.;
Sacks,
D;
Soto,
M.
Vaccination
with
the

Leishmania
infantum
acidic
ribosomal
P0
protein
plus
CpG
oligodeoxynucleotides
induces

protection
against
cutaneous
leishmaniasis
in
C57BL/6
mice
but
does
not
prevent

progressive
disease
in
BALB/c
mice.
Infection
and
Immunity
73,
5842-­-5852
(2005).

75
Melby,
P.
C.;
Ogden,
G.
B.;
Flores,
H.
A.;
Zhao,
W.;
Geldmacher,
C.;
Biediger,
N.
M.;
Ahuja,
S.

K.;
Uranga,
J.;
Melendez,
M.
Identification
of
vaccine
candidates
for
experimental
visceral

leishmaniasis
by
immunization
with
sequential
fractions
of
a
cDNA
expression
library.

Infection
and
Immunity
68,
5595-­-5602
(2000).

76
Stober,
C.
B.;
Lange,
U.
G.;
Roberts,
M.
T.;
Gilmartin,
B.;
Francis,
R.;
Almeida,
R.;
Peacock,
C.

S.;
McCann,
S.;
Blackwell,
J.
M.
From
genome
to
vaccines
for
leishmaniasis:
screening
100

novel
vaccine
candidates
against
murine
Leishmania
major
infection.
Vaccine.
24,
2602-­-
2616
(2006).

77
Iborra,
S.;
Parody,
N.;
Abanades,
D.
R.;
Bonay,
P.;
Prates,
D.;
Novais,
F.
O.;
Barral-­-Netto,
M.;

Alonso,
C.;
Soto,
M.
Vaccination
with
the
Leishmania
major
ribosomal
proteins
plus
CpG

oligodeoxynucleotides
induces
protection
against
experimental
cutaneous
leishmaniasis

in
mice.
Microbes
Infection
10,
1133-­-1141
(2008).

78
Chavez-­-Fumagalli,
M.
A.;
Costa,
M.
A.;
Oliveira,
D.
M.;
Ramirez,
L.;
Costa,
L.
E.;
Duarte,
M.
C.;

Martins,
V.
T.;
Oliveira,
J.
S.;
Olortegi,
C.
C.;
Bonay,
P.;
Alonso,
C.;
Tavares,
C.
A.;
Soto,
M.;

Coelho,
E.
A.
Vaccination
with
the
Leishmania
infantum
ribosomal
proteins
induces

protection
in
BALB/c
mice
against
Leishmania
chagasi
and
Leishmania
amazonensis

challenge.
Microbes
and
Infection
12,
967-­-977
(2010).

79
Ramirez,
L.;
Iborra,
S.;
Cortes,
J.;
Bonay,
P.;
Alonso,
C.;
Barral-­-Netto,
M.;
Soto,
M.
BALB/c

mice
vaccinated
with
Leishmania
major
ribosomal
proteins
extracts
combined
with
CpG

oligodeoxynucleotides
become
resistant
to
disease
caused
by
a
secondary
parasite

challenge.
Journal
of
Biomedicine
&
Biotechnology
2010,
181690
(2010).

80
Launois,
P.;
Maillard,
I.;
Pingel,
S.;
Swihart,
K.
G.;
Xenarios,
I.;
Acha-­-Orbea,
H.;
Diggelmann,

H.;
Locksley,
R.
M.;
MacDonald,
H.
R.;
Louis,
J.
A.
IL-­-4
rapidly
produced
by
V
beta
4
V
alpha

8
CD4+
T
cells
instructs
Th2
development
and
susceptibility
to
Leishmania
major
in

BALB/c
mice.
Immunity
6,
541-­-549
(1997).

81
Julia,
V.;
Rassoulzadegan,
M.;
Glaichenhaus,
N.
Resistance
to
Leishmania
major
induced
by

tolerance
to
a
single
antigen.
Science
274,
421-­-423
(1996)

82
Gonzalez-­-Aseguinolaza,
G.;
Taladriz,
S.;
Marquet,
A.;
Larraga,
V.
Molecular
cloning,
cell

localization
and
binding
affinity
to
DNA
replication
proteins
of
the
p36/LACK
protective

antigen
from
Leishmania
infantum.
European
Journal
of
Biochemistry
259,
909-­-916

(1999).

83
Lopez-­-Fuertes,
L.;
Perez-­-Jimenez,
E.;
Vila-­-Coro,
A.
J.;
Sack,
F.;
Moreno,
S.;
Konig,
S.
A.;

Junghans,
C.;
Wittig,
B.;
Timon,
M.;
Esteban,
M.
DNA
vaccination
with
linear
minimalistic

(MIDGE)
vectors
confers
protection
against
Leishmania
major
infection
in
mice.
Vaccine

21,
247-­-257
(2002).

84
Pinto,
E.
F.;
Pinheiro,
R.
O.;
Rayol,
A.;
Larraga,
V.;
Rossi-­-Bergmann,
B.
Intranasal
vaccination

against
cutaneous
leishmaniasis
with
a
particulated
leishmanial
antigen
or
DNA
encoding

LACK.
Infection
and
Immunity
72,
4521-­-4527
(2004).

85
Gomes,
D.
C.;
Pinto,
E.
F.;
de
Melo,
L.
D.;
Lima,
W.
P.;
Larraga,
V.;
Lopes,
U.
G.;
Rossi-­-
Bergmann,
B.
Intranasal
delivery
of
naked
DNA
encoding
the
LACK
antigen
leads
to

262